Westfield Capital Management Reduces Stake in GE HealthCare Technologies

Institutional investor trims position in medical technology company by over 99%

Mar. 3, 2026 at 7:39am

Got story updates? Submit your updates here. ›

Westfield Capital Management Co. LP, a major institutional investor, has significantly reduced its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 99.3% during the third quarter, according to a recent filing with the Securities and Exchange Commission. The firm now owns just 4,322 shares of the company's stock, down from over 600,000 shares previously.

Why it matters

GE HealthCare Technologies is a leading global medical technology and diagnostics company, so changes in major institutional ownership can signal shifts in investor sentiment and market expectations for the firm. Westfield Capital's dramatic reduction in its GEHC position may indicate broader concerns about the stock's near-term performance or the company's outlook.

The details

According to the SEC filing, Westfield Capital Management sold 626,861 shares of GE HealthCare Technologies during the third quarter, leaving the firm with just 4,322 shares worth approximately $325,000. The sale represents a 99.3% reduction in Westfield's position in the company. GE HealthCare Technologies, which was spun off from General Electric in 2023, is a major player in diagnostic imaging, patient monitoring, and other medical technology products and services.

  • Westfield Capital Management reduced its stake in GE HealthCare Technologies during the 3rd quarter of 2025.

The players

Westfield Capital Management Co. LP

A major institutional investment firm that has significantly reduced its stake in GE HealthCare Technologies.

GE HealthCare Technologies Inc.

A global medical technology and diagnostics company that was spun off from General Electric in 2023.

Got photos? Submit your photos here. ›

The takeaway

Westfield Capital's dramatic reduction in its GE HealthCare Technologies position could signal broader concerns about the company's near-term outlook or performance, though the reasons behind the move are not entirely clear. Investors will likely be watching to see if other major institutional holders make similar adjustments to their GEHC positions in the coming quarters.